GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the TSG101 uev domain in complex with FA258 peptide

Analyse Crystal structure of the TSG101 uev domain in complex with FA258 peptide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3P9H
Type
protein
Length
150 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tumor susceptibility gene 101 protein; Gag polyprotein
UniProt
Q99816, Q9YP46
Ligands
ACE, NH2

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATumor susceptibility gene 101 proteinprotein14128% helix, 33% strandQ99816
BGag polyproteinprotein90% helix, 11% strandQ9YP46

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B
  • NH2 · Amino group · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 739 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, nonstandard).

Compared structures

  • 3P9H · Crystal structure of the TSG101 UEV domain in complex with FA258 peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99816 · AlphaFold monomer V2.0 prediction for tumor susceptibility gene 101 protein (Q99816) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.